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Abstract. Requirements traceability helps to ensure software quality. It supports quality
assurance activities such as impact analysis, regression test selection, compliance verification
and validation of requirements. Its implementation has long been promoted by the research and
expert practitioner communities. However, evidence indicates that few software organizations
choose to implement traceability processes, in the most part due to cost and complexity issues.
Organizations operating within the safety critical domains are mandated to implement
traceability, and find the implementation and maintenance of an efficient and compliant
traceability process a difficult and complex issue.
Through interviews with a medical device SME, this paper seeks to determine how
traceability is implemented within the organization, the difficulties it faces in implementing
traceability, how compliant it is with the medical device standards and guidelines, and what
changes could be made to improve the efficiency of their traceability implementation and
maintenance.
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1 Introduction
The importance and role of traceability in supporting software development have
been long recognised [1]. Requirements tracing helps ensure that the customers’
requirements are being met and that the quality of the final product is maximised while
minimising costly rework due to errors in the requirements. Traceability through the
software development and risk management process is particularly important in safety
critical industries such as the medical device domain, where it is incumbent on
manufacturers to produce safe software [2].
The effect of poor quality medical device software can be seen from the recent
announcement by Johnson & Johnson that some of its Animas insulin pumps will
become defunct at the stroke of midnight on December 31, 2015. The company has
warned European regulators that the pumps will stop delivering insulin at the start of
2016 and will generate a "call service alarm" due to a software fault. During November
2012 the company began to warn patients of the impending malfunction, offering to
replace devices that have warranties that will still be in effect when the software glitch
is expected to hit [3].
Organizations building safety critical systems are often legally required to
demonstrate that all parts of the code trace back to valid requirements. Laws such as
the US Sarbanes-Oxley Act 2002 [4] require organizations to implement change
management processes with explicit traceability coverage for any parts of a software
product that potentially impact the balance sheet [5].
Regulations and guidelines exist to assist medical device organisations to produce
quality software. The documents which medical device manufacturers must adhere to
are IEC 62304 [6] (which is endorsed by the European Union and the U.S.), FDA
Guidance for the Content of Pre-market Submission for Software in Medical Devices
[7], FDA General Principles of Software Validation(GPSV) [8], FDA Off-the Shelf
Software Use in Medical Devices [9] and ISO 14971 [10]. These documents
emphasise to different degrees the requirement for traceability through the software
development lifecycle (SDLC), risk management and change management processes.
Understanding the different degrees of requirements for traceability and implementing
those requirements is a difficult and complex task for a medical device small to
medium enterprise (SME). A lack of detailed guidance and direction on how to
implement and maintain traceability could lead to many medical device SMEs
implementing inefficient and/or non-compliant traceability processes [11].
The objective of this paper is to analyse the requirements for traceability as
detailed in the medical device standards and guidelines documents and to highlight
the varying requirements for traceability between these documents. The authors
conducted detailed interviews with a medical device SME in order to determine what
processes are being used to implement traceability, difficulties faced in implementing
traceability, how compliant the organisation is, and what changes could be made to
improve the efficiency of traceability implementation and maintenance.
This paper has been divided into 7 sections. Related work in Section 2 explains the
concept of traceability and reveals why its implementation is important. Section 3
details the requirements for traceability as prescribed by the medical device standards
and guidelines. Section 4 list the aims of the study and the approach used to achieve
those aims and also details the organisation profile. Section 5 summarises the
implementation of traceability within the organisation and highlights difficulties faced
by the organisation in implementing traceability. Section 6 discusses the difficulties
that the organisation face in implementing traceability and ways in which it might
overcome these difficulties and become more efficient.
2 Related Work
In engineering terms a trace is comprised of a source artifact, a target artifact and the
link between them [12]. Traceability is the ability to establish and use these traces.
Numerous definitions for traceability exist in the literature but one of the most
popular and encompassing is:
"Requirements traceability refers to the ability to describe and follow the life
of a requirement, in both a forwards and backwards direction (i.e., from its
origins through its development and specification to its subsequent
deployment and use, and through all periods of on-going refinement and
iteration in any of these phases "[13].
In general, traceability is about understanding a design right through from the origin
of the requirement to its implementation, test and maintenance. Traceability allows us
to understand many important aspects of a project such as; are the customers’
requirements being met, the specific requirements that an artefact relates to, the
origins and motivation of a requirement, and what are the requirements associated
with this test case. Traceability supports critical activities such as compliance
verification, impact analysis, and regression test case selection[14].Traceability helps
ensure that ‘quality’ software is developed.
Traceability is about linking requirements to artefacts in the software development
environment. This environment includes technical aspects (e.g. specifications,
diagrams and code) and social aspects (e.g. people, policies, decisions etc.).
Traceability was initially used to trace requirements from their source to
implementation and test, but now plays an increasing role in defect management,
change management and project management. Traceability links represent an
important source of information for project managers, analysts, designers,
maintainers, and end users. Increasingly software development is globally distributed
across multiple teams and sites which makes traceability even more important [11].
As traceability provides an essential support for developing high quality software
systems [15] it is vital to engage an efficient traceability process.
Unfortunately, establishing and maintaining traceability links between software
artefacts is a time consuming, error prone, and labour intensive task. Consequently,
despite the advantages that can be gained, explicit traceability is rarely established
unless there is a regulatory reason for doing so [16]. In safety critical domains such as
the medical device domain traceability information can also be used when certifying a
safety-critical product to show that all requirements were implemented and covered
by specific tests.
3 Traceability Requirements for Compliance within Medical
Device Standards
The requirements for traceability through the SDLC are not transparent from the
medical device regulations; in fact the regulations make little or no reference to
traceability. However the medical device standards and guidelines mandate traceability
throughout the SDLC and within supporting processes such as change management
and risk management.
Figure 1 indicates the requirements for traceability through the SDLC, Risk and
Change management processes. The letters A to E refer to the medical device
standards and guidelines and are listed in Table 1. The obvious point of note is the
variance in the requirements between the standards with only the FDA’s General
Principles of Software Validation document requiring traceability to the module and
function level
Figure 2 indicates the medical device standards and guidelines requirements for
traceability within the Change management and Risk management processes. While
each of the standards require full traceability through the risk management process,
only IEC 62304 requires traceability within the change management process
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4 Methodology
4.1 Aims and method.
The aim of our case study was to answer the following research questions:
1. What is the traceability practice within a medical device SME?
2. Is this practice compliant with medical device standards and guidelines?
3. Is the process used to implement and maintain traceability efficient and
compliant?
4. How could this process be improved?
To be able to answer these questions a qualitative study was conducted in which 2
people from the organization were interviewed. These 2 people were chosen as the
organization thought they were the most knowledgeable people in the organization
with regards to traceability implementation and maintenance. The job titles of the
two people involved were Chief Technical Officer and Software Development
Manager. Each interview comprised 60 questions and lasted between 2 hours and, 2
hours and 30 minutes; the interviews were recorded and later transcribed and
summarized. The questions were developed in such a way as to determine the
following:
1. Between what stages of the software development lifecycle did the
organisation trace e.g. Do you trace from software requirements to design?
2. How do they implement traceability e.g. How do you trace from software
requirement to design?
3. What are the stages of the risk management process and how do they provide
traceability between each stage e.g. How do you ensure that each hazard has
a corresponding risk control measure, if required?
4. What are the stages of the change management process and how do provide
traceability between each stage e.g. IEC 62304 requires the manufacturer to
create an audit trail where each change specification, problem report or
change request, and each approval of the change request can be traced. Can
you explain how you meet this requirement?
5. Difficulties the organisation encountered in implementing and maintaining
traceability e.g. What difficulties do you have with implementing or
maintaining traceability?
6. Any ideas for improvements the organisation had with regard to
implementation and maintenance of traceability e.g. how do you think your
present traceability process could be improved?
7. Any process improvement initiatives the organization were currently or were
planning to undertake e.g. What process improvements are you working on
or plan to work on?
4.2 Organization profile
The organization, who’s headquarters are based in the UK, has a research and
development and manufacturing facility based in Ireland. This study was carried out
in the Ireland facility. The organization employs 60 to 70 people and sometimes
employs contractors on a part time basis so the numbers can fluctuate. The products
are marketed globally into the primary care market, secondary care, occupational
health, sports medicine and clinical trials. Their products are rated as software safety
classification II, meaning non-serious injury to the patient or operator of the device is
possible due to a defect in the device. The organization uses the V model for their
software development. (The V model, like the waterfall model is a sequential path for
the execution of processes. Each phase must be completed before the next phase
begins. Testing of the product is planned in parallel with a corresponding phase of
development. The V model is popular with medical device software development
organizations). The organization’s main software development process covers class II
(non-serious injury is possible e.g. x-ray systems, gas analyzers, pump) & class III
(Class III medical devices have the most stringent regulatory controls). They have a
separate process for any class I medical device (have the least amount of regulatory
control and present minimal potential harm to the user development e.g. tongue
depressors, arm slings) they produce.
5 Findings
This section presents the major findings from the interviews held with the
organization, beginning with the strategy the organization uses to implement
traceability through the SDLC, risk management and change management processes.
Additionally the difficulties the organization faces in implementing traceability and
any improvements proposed by the organization are unfolded
5.1 Traceability Strategy
The organization have a traceability standard operating procedure which basically
is a document detailing how to fill in their traceability matrix (template for matrix is
provided which provides consistency). The traceability matrix is ‘user requirement’
driven i.e. user requirements are listed in the first column then all software
requirements that satisfy that user requirement are listed in the second column.
Subsequent columns list architectural design, detailed design, risk analysis and test
cases). Their quality management procedures say who should
complete the matrix, when and how often. In a recent project the CTO updated the
user requirement column in the traceability matrix, the development team updated the
software requirement, architectural and detailed design columns and QA updated test.
The software development manager is ultimately responsible for ensuring the matrix
gets done as and when it should get done and CTO is responsible for approving it at
the end.
Bi-directional traceability is implemented through a mixture of in-document
tracing and by tracing through the traceability matrix. Bi-directional traceability exists
from user requirements to software requirements (through the traceability matrix and
through the documents, e.g. the software requirement spec will indicate the
corresponding user requirement related to each software requirement). Bi-directional
traceability somewhat exists between software requirements and architectural and
detailed design). The organization “does not do ‘within document’ tracing in the
design documents. The only way to trace back from design is to search through the
traceability matrix for each design component, and, as a design component might
satisfy more than one user requirement, this might be a long and laborious task”. The
organization has traceability between requirements and test and between design and
test, through the traceability matrix. They do not have traceability between code and
test.
Traceability from each specification document to the author of that document was
evident because each document has the author, reviewer and approver with their
signatures and date and each document has an issue control sheet.
Establishing traceability from test to test equipment and its calibration records is
documented within the organization’s software test plan and not in the risk analysis
document.
5.2 Traceability through Risk management
The organization has a Product Risk Management document and a Software Risk
Management document. Risk analysis is documented in the risk management
document. Risk analysis starts at the User requirements phase and is done at every
subsequent phase. Every software requirement is reviewed for potential cause of harm
and given a risk classification and may also be given a prioritization based on
potential for harm and how easy it is to detect. Based on the risk classification and/or
prioritization the organization decides on what mitigations to implement (e.g. change
to design, product labeling, training, and user manuals). Software QA validate the
mitigations after they have been implemented and then the risks get re-classified
hopefully to an acceptable level. “Each step of risk analysis, risk control
implementation and validation is traceable through the risk management document”.
The software risk analysis has different categories. Usability is an example of a
category. “You might see a number of requirements under the Usability heading but
you might also see the same requirement under a number of different headings. So the
organization has traceability at the risk analysis level and also the top level
requirements traceability matrix”. If there is a change to core product (e.g.
introduction of a new feature) the risk analysis document gets updated to a new issue
specifying what was added and why.
5.3 Traceability through Change Management
Changes can happen for a number of reasons e.g. a bug, a customer request, the
natural progression and maintenance of the software or from a complaint.
If it’s a bug they document the issue, the investigation and the results of the
investigation, what corrective action if any is required and if the corrective action
requires the software to be updated. For any change that requires a change to the
software the organization use a Software Changes Specification (SCS). The SCS
records any changes to the software, risk associated with the change, impact in terms
of other requirements. Traceability is maintained throughout by linking each change
to risk and impact. The traceability matrix gets updated during a mini software
lifecycle enacted for this change. For any change QA have to do a test plan and test
cases, do a test summary to show what tests didn’t pass and provide the relevant
traceability in a test report. On the other hand a customer may request a change for a
clinical trial. The organization use a Customer Requirement Specification (CRS) for
this instead of a URS and that drives SCS and a mini lifecycle where the traceability
matrix gets updated. Software change requests (from marketing or from a customer
for example) are logged in an Excel Spreadsheet recording who logged it, when and
why it was logged, and any attachments. For the natural progression and maintenance
of software the URS gets updated with new or removed features (along with the
traceability matrix) and that goes through the full lifecycle again which means new
test plans, new test cases etc. The software requirements, architectural and detailed
design specifications also get updated. Complaints are logged in SmartSolve (a
document control system) along with investigations, results, and corrective actions.
SmartSolve is 21CFR Part 11 compliant so records full electronic signatures. The
rationales for customer complaints and for product modifications are recorded
(because they have to justify the reason for change). The rationale for requirements in
general is not recorded.
5.4 Traceability benefits
The organization recognized two benefits of traceability i.e. “it is easy to see if all
the requirements have been tested” and “a matrix is useful when getting audited”. The
organization does not use the traceability matrix for instruments such as impact
analysis, because; (i) with their experience they can tell what the impact of a
requirement change will be from a review of the requirement specification and (ii) the
fact that the matrix tends to contain requirement numbers which don’t give any detail
of what the requirement does so reference to the requirement specification is still
required. Putting the required detail into the traceability matrix would make it
absolutely massive.
5.5 Downside to traceability and their process
As traceability is manually implemented in an Excel spreadsheet, the organization
found this task to be complex and burdensome. This complexity, coupled with the fact
that the organizations felt that the real benefit of having traceability is to satisfy
auditors, means that traceability matrix is often not filled out until the project is at or
near completion. In fact the general attitude is that the organization “probably would
not concern themselves with traceability but for the fact that they are mandated to do
so”.
In a manual system you have to maintain a consistent numbering scheme for the
duration of the product’s life, so for example if someone releases a new issue of a
requirements specification and re-numbers everything then you’ve lost your
traceability; an electronic tool would automatically update everything and traceability
wouldn’t get lost.
In general, staff was trained in their organization’s processes and procedures
(including traceability procedures). However there was a lack of understanding of the
benefits of traceability and there were no plans in place to address this.
Largely the organization was compliant with the medical device standards and
guidelines requirements for traceability (as detailed in Section 3) but there were areas
which they were unsure about and would require some guidance e.g. the organization
did not trace to code level which is an FDA requirement.
5.6 Traceability tools
Traceability was implemented through a traceability matrix using Excel (along
with some in-document tracing). The organization admits that using Excel is not very
efficient and painful to update. The organization does not use a dedicated traceability
tool for the following reasons:
a) Time constraints: It was felt that a lot of time was needed to investigate the
suitability of the range of tools on the market and no-one was given the
responsibility for doing this
b) Cost: It was thought that the cost of purchasing and implementing a
traceability tool might not be something that they could justify. One tool (although
it was a full application lifecycle management tool) they had considered “was
100,000 euro and that, even if they had the money, they could not justify spending
that amount”.
c) Compliance: issues over the tools not being able to output a full traceability
matrix and also failure to meet Title 21 CFR Part 11 requirements which details
the FDA’s requirements for electronic records and electronic signatures to be
trustworthy, reliable and essentially equivalent to paper records and handwritten
signatures.
d) Tool stability: The organization felt that tools that might be affordable to
them would likely not provide the necessary stability and support that they would
require e.g. after considering another tool they didn’t have confidence in it as there
seemed to be only a small group of people involved in the organization and they
were concerned about future support and stability issues. Another concern was that
the medical device process within the tool is a third part add-on. “It is a big
decision for an organization to move their process to an electronic format, one
which we would not be prepared to take unless we had an affordable, stable and
fully compliant tool”.
5.7 Process improvement
At present the organization has a process improvement initiative in place. The
organization has hired a person to gather metrics for software QA (metrics to
highlight what are the functional areas that are causing issues, and why are they
causing issues etc.). It was something they had done in the past but had fallen away.
Presently the organization feels that too much of the quality issues are being left to
QA and that development needs to take more responsibility; this was highlighted
recently when contractors were hired and their code was absolutely solid because they
were writing unit test cases for absolutely everything they did. The organization’s
process states that they will do unit testing on functional areas that QA cannot test via
their functional testing, just to make sure they have coverage of everything. So at
present every requirement will have a test case or a unit test and code review, or
maybe both if it was that critical a requirement.
The organization feel that their traceability process could be improved by use of a
traceability tool, “making it part of everyday work, ensuring traceability gets done
and kept up to date”, as at the moment it seems that the traceability matrix only gets
filled in towards the end of a project and is mainly used to satisfy auditors. From the
organization’s perspective if they were not required to do traceability then they might
not do it as they find it laborious and they don’t get the full benefit of it.
6 Discussion
The organization finds traceability implementation to be a laborious and complex
task and feel that the use of a traceability tool to help automate the process would be
of great benefit. Using an Excel spreadsheet to create a traceability matrix has several
disadvantages such as static and sometimes outdated information, hours wasted in
creating the document and no proactive notification capabilities. Effective traceability
tools will output up-to-date information, impact analysis reports and a traceability
matrix and reduce the complexity involved. It is somewhat surprising then that
multiple studies have found the level of commercial traceability tool adoption to be
around 50 percent throughout industry. The majority of the remaining companies
utilize manual methods and a small percentage develop their own in-house
traceability tools [17].
The organization sees the main benefit of traceability as being one of satisfying
auditors and only implements traceability because they are mandated to do so. The
organization doesn’t fully understand the potential benefits of traceability and,
although they have a standard operating procedure in place, its implementation is not
being driven by management. An organizational policy stating the organization’s
policy with regard to traceability along with an education program on the benefits of
traceability can help developers and management understand the importance of
implementing and maintaining traceability when changes occur.
7 Conclusion
The organization uses two manual approaches to implement traceability i.e. in-
document tracing and an excel traceability matrix. A traceability standard operating
procedure outlines how to complete the traceability matrix. It is the software
engineering manager’s responsibility to ensure that the matrix gets completed and it is
then signed off by the chief technical officer.
From an auditors perspective the organization would seem to be reasonably
compliant, as they implement traceability through the risk management and change
management processes and in the most part through the SDLC, although there may be
a compliance issue as the organization does not meet the FDA requirement for tracing
to the level of code as detailed in Section 3.
However the organization acknowledges that the implementation and maintenance
of traceability is a burdensome, inefficient, complex and an inadequately executed
task. It is felt that the introduction of a traceability tool would improve efficiency and
diminish the burdensome nature of the task. An education program on the benefits of
implementing and maintaining traceability would help both management and
developers to understand the importance of traceability to producing quality software.
The probable result thus being a traceability process adhered to by all relevant
personnel, and not just a traceability matrix to be completed at the end of the project
for inspection purposes.
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